T1	Outcomes 0 62	Serum bactericidal activities and comparative pharmacokinetics
T2	Outcomes 106 163	pharmacokinetics and serum bactericidal activities (SBAs)
T3	Outcomes 382 428	concentrations of the drugs in serum and urine
T4	Outcomes 448 497	bioassay and high-pressure liquid chromatography.
T5	Outcomes 631 694	mean concentrations of imipenem and meropenem measured in serum
T6	Outcomes 754 772	urinary recoveries
T7	Outcomes 855 895	areas under the concentration-time curve
T8	Outcomes 1412 1416	SBAs
T9	Outcomes 1438 1481	microdilution method of Reller and Stratton
T10	Outcomes 1591 1626	Mean reciprocal bactericidal titers
T11	Outcomes 1700 1704	SBAs
T12	Outcomes 2094 2104	half-lives
T13	Outcomes 2184 2227	SBAs against clinically important pathogens
T14	Outcomes 2259 2262	SBA
T15	Outcomes 2308 2311	SBA
